- Previous Close
0.2160 - Open
0.2100 - Bid 0.2200 x --
- Ask 0.2281 x --
- Day's Range
0.2100 - 0.2250 - 52 Week Range
0.1590 - 0.3600 - Volume
56,688 - Avg. Volume
10,637 - Market Cap (intraday)
25.968M - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia therapy for cancer treatment; and nanomedical therapy for the treatment of colorectal cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; bovine TB tests; and concussion screening tests. Sona Nanotech Inc. was founded in 2013 and is based in Halifax, Canada.
www.sonanano.com--
Full Time Employees
October 31
Fiscal Year Ends
Sector
Industry
Recent News: SNANF
View More
Performance Overview: SNANF
Trailing total returns as of 3/19/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SNANF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SNANF
View MoreValuation Measures
Market Cap
25.98M
Enterprise Value
24.95M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
14.43
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-54.65%
Return on Equity (ttm)
-147.31%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.7M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
1.86M
Total Debt/Equity (mrq)
15.73%
Levered Free Cash Flow (ttm)
-926.08k
Company Insights: SNANF
SNANF does not have Company Insights